Liège, Belgium, 04 July 2018, 18:00 CEST – Regulated Information – Mithra Pharmaceuticals SA/NV (Euronext Brussels: MITRA) today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from Meusinvest SA, having its registered seat located at 4000 Liège, Rue Lambert Lombart 3, on 02 July 2018.